Mar. 6, 2017…IRVINE, Calif.…Harbor MedTech, a commercial-stage regenerative medicine company delivering innovative biologic wound-healing products, today announced that Jerry Mezger, President and CEO, will present at the 29th Annual ROTH Conference.
The presentation is scheduled to begin at 8:40 a.m. PT on March 14, 2017 at The Ritz-Carlton-Laguna Niguel.
Harbor is developing innovative products addressing critical patient and clinician unmet needs in key areas including chronic wounds, hernia, joint repair, and plastic surgery. Architect®, the company’s first product using its BriDGE® tissue regeneration technology, is a collagen matrix that heals chronic skin wounds faster compared to other skin substitutes in as few as one application.
Members of the investment community who are interested in meeting with Harbor’s management team during the conference event should contact their ROTH representative or Jerry Mezger at Harbor MedTech, at (949) 679-4800 or email@example.com.
About Harbor MedTech
Harbor MedTech, Inc., is a commercial-stage regenerative medicine company that has pioneered a new technology platform for biologic wound healing products. The company’s BriDGE® platform is a major leap forward in tissue regeneration—offering exceptional performance, proven clinical results, and an excellent economic advantage. Architect®, the company’s first BriDGE-based product, has been shown to heal chronic skin wounds with just one application—versus the multiple applications required with other collagen-based skin substitutes. Recent studies demonstrate that it may act by stimulating the patient’s own immune system to accelerate healing. Harbor MedTech was founded in 2010 and is based in Irvine, Calif.
For more information visit www.harbormedtech.com.
Jon Zalk, Harbor MedTech
(949) 679-4800, firstname.lastname@example.org